Blood-based marker for Alzheimer's disease shows diagnostic potential

February 2, 2018, Alzheimer's Research UK
Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.

Researchers in Japan and Australia have used the ratio of different forms of the hallmark Alzheimer's protein, amyloid, in blood to detect those who have high levels of the protein in their brain. Their findings are published today in the scientific publication Nature and take researchers a step closer to developing a blood test for the Alzheimer's protein.

The is known to build up in the during Alzheimer's, creating clumps of protein known as plaques. Previous research has shown that people with Alzheimer's disease also tend to have more amyloid in their blood and spinal fluid than healthy people. However, these markers are not yet accurate enough to be used successfully as a tool when diagnosing Alzheimer's in the clinic.

There are several different forms of the amyloid protein, some more sticky and harmful than others. This new study presents an approach to measure specific forms of in the blood, suggesting a potential new technique to help diagnose the disease. Scientists measured the ratios of different forms of blood amyloid and compared the findings to amyloid levels in the brain using multiple PET scans.

The researchers studied two different groups of people, one from Japan and another from Australia to help confirm their results. Researchers found that a measurement that included multiple ratios of blood amyloid type could improve how well they were able to predict the amount of amyloid in the brain on brain scans.

Dr. Carol Routledge, Director of Research at Alzheimer's Research UK, said:

"We know that damaging changes begin to take place in the brain many years before the symptoms of Alzheimer's appear, and researchers are now developing new ways to detect the earliest signs of the disease. Searching for reliable markers of disease in blood is a tricky task, as can be influenced by so many factors that differ between individuals.

"This robust study finds the ratio of slightly different forms of amyloid in the blood ties in well with signs of Alzheimer's disease on , a useful step in validating its potential as a diagnostic tool. The study uses data from two countries, which helps overcome differences found in people across locations that is a common problem in blood biomarker studies, and its accuracy in predicting amyloid in the brain is higher than other previous attempts. Given the risk of false positives or negatives from tests like this, further work with more people will need to build on this study to understand how well this approach could predict those who will go on to develop symptoms of Alzheimer's in the future.

"A marker for Alzheimer's could prove valuable as a minimally invasive and cost-effective addition to the current diagnostic tests available for the disease. The ability to detect the very earliest stages of Alzheimer's would not only allow people to receive existing treatments sooner but would also enable new drugs to be trialled in the right people, at the right time."

Explore further: Alzheimer's drug targeting soluble amyloid falls short in a large clinical trial

Related Stories

Alzheimer's drug targeting soluble amyloid falls short in a large clinical trial

January 25, 2018
A paper published today in the New England Journal of Medicine reports that solanezumab, a monoclonal antibody-based treatment for Alzheimer's disease developed by Eli Lilly that targets amyloid plaques, did not significantly ...

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Blood test identifies key Alzheimer's marker

July 19, 2017
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid in their ...

Alzheimer's disease might be a 'whole body' problem

October 31, 2017
Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns ...

Brain amyloid PET scans enhance the diagnosis of Alzheimer's

July 17, 2017
The build-up of amyloid protein in the brain is a hallmark feature of Alzheimer's disease, and its detection often relies on the testing of brain and spinal fluid samples. More recently, PET brain scans have been able to ...

Sleep problem linked to changes in hallmark Alzheimer's protein

November 10, 2017
Researchers in the US have found a link between the sleep disorder, obstructive sleep apnoea, and levels of a protein involved in Alzheimer's disease. Their findings are published today in the American Journal of Respiratory ...

Recommended for you

Neurons with good housekeeping are protected from Alzheimer's

December 17, 2018
Some neurons in the brain protect themselves from Alzheimer's with a cellular cleaning system that sweeps away toxic proteins associated with the disease, according to a new study from Columbia University and the University ...

Growing a brain: Two-step control mechanism identified in mouse stem cells

December 17, 2018
Scientists have identified two distinct control mechanisms in the developmental transition of undifferentiated stem cells into healthy brain cells. This fundamental research using mice may inform regenerative medicine treatments ...

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.